ARCA biopharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1994
Net Income	-5.34	-9.93	-19.32	-9.74	-5.48	-7.93	-18.49	-16.44	-11.45	-9.69	Upgrade
Depreciation & Amortization	0.11	0.11	0.09	0.09	0.09	0.02	0.36	0.32	0.21	0.08	Upgrade
Share-Based Compensation	0.69	0.56	0.5	0.04	0.15	0.27	0.46	0.58	0.6	0.65	Upgrade
Other Operating Activities	-0.47	-1.66	-0.03	1.88	0.44	-0.61	0.2	0.56	0.1	-0.44	Upgrade
Operating Cash Flow	-5.01	-10.91	-18.76	-7.73	-4.8	-8.24	-17.47	-14.99	-10.53	-9.41	Upgrade
Capital Expenditures	0	-0	-0.04	-0.02	-0	-0	-0	-0.01	-0.01	-0.02	Upgrade
Change in Investments	0	0	0	0	0	3.05	12.93	-16.4	0	0	Upgrade
Investing Cash Flow	0	-0	-0.04	-0.02	-0	3.05	12.93	-16.41	-0.01	-0.02	Upgrade
Share Issuance / Repurchase	0	0	24.07	50.89	7.28	3.53	6.55	0	37	9.04	Upgrade
Debt Issued / Paid	0	0	0	-0.41	-0.35	-0.31	-0.26	0	-0.19	-0.18	Upgrade
Other Financing Activities	-	-	-0.98	-2.03	-0.37	-0.12	-0.45	-	-2.81	-0.84	Upgrade
Financing Cash Flow	0	0	23.09	48.45	6.56	3.1	5.85	0	33.99	8.02	Upgrade
Net Cash Flow	-5.01	-10.91	4.29	40.71	1.76	-2.09	1.3	-31.4	23.45	-1.4	Upgrade
Free Cash Flow	-5.01	-10.91	-18.81	-7.74	-4.81	-8.25	-17.48	-15	-10.55	-9.43	Upgrade
Free Cash Flow Per Share	-0.35	-0.76	-1.35	-1.64	-3.64	-10.72	-30.15	-29.77	-30.18	-57.93	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).